Navigation Links
Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
Date:9/23/2010

ng with type 2 diabetes. The PROactive trial demonstrated that although there was no statistically significant difference between ACTOS and standard-of-care alone for the primary endpoint, there was no increase in mortality or total macrovascular events with ACTOS. This safety information has been included in both the FDA-approved product label and EMA-approved Summary of Product Characteristics (SPC) since 2007, providing patients and health care professionals with additional relevant information regarding the CV safety profile of ACTOS.

Takeda is the inventor and developer of ACTOS, which was launched commercially in 1999. ACTOS, as labeled, is an effective and appropriate treatment option for many people living with type 2 diabetes. Certain patients with heart failure should not start taking ACTOS. ACTOS can cause new or worsen heart failure. In clinical trials using ACTOS in monotherapy, the most common adverse events (greater than or equal to 5%) were upper respiratory tract infection, headache, sinusitis, myalgia, tooth disorder, aggravated diabetes mellitus and pharyngitis. Please see additional important safety information continued below.

About ACTOS® (pioglitazone HCl) Indications and Usage

ACTOS is a prescription medication used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. ACTOS has been studied as a monotherapy and in combination with sulfonylurea, metformin, or insulin. ACTOS should always be used according to Health Care Provider directions and its Complete Prescribing Information.

Important Safety Information

ACTOS is not for everyone. Certain patients with heart failure should not start taking ACTOS. ACTOS can cause new, or worsen, heart failure. Patients should talk to their doctor immediately if they experience unusually fast weight gain, fluid retention (swelling), shortness of breath, or unusual tiredness.

<
'/>"/>
SOURCE Takeda Pharmaceutical North America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arthritis Foundation and Takeda Launch First-Ever National Gout Public Service Announcement (PSA) Campaign, Urging People Living With Gout to Keep Enjoying Lifes Simple Pleasures
2. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
3. Takeda Responds to FDA Advisory Committee Recommendation
4. Takeda Provides Update on Patent Litigation for ACTOS(R) (pioglitazone HCl) and ACTOplus met(R) (pioglitazone HCl and metformin HCl) in the U.S.
5. CellCentric Licenses Novel Epigenetic Discovery Programme to Takeda
6. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
7. Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate)
8. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
9. Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences
10. Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico, Turkey and Five Other Countries in Europe
11. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... , April 27, 2015  As the Innovation Insight ... Philadelphia , InCrowd, provider of on-demand answers ... of life science insights experts in charting a new ... and innovation in research. Presented jointly by ... by Communispace Health, IIeX Health features TED-style presentations and ...
(Date:4/27/2015)... 2015 - The First Company in ... State Intellectual Property Office of China ... - A New Treatment Which Offers Hope for ... - About 20% of Elderly Urban Chinese Suffer From Peripheral ... Higher Than in Men. CLI is a Progressive Form of ...
(Date:4/26/2015)... , April 26, 2015 Cancer experts ... VAR ) supported project in the area of distributed ... data" for the benefit of patients. Speakers at a ... Society for Therapeutic Radiation Oncology) forum in Barcelona ... treatment and applying that knowledge to help benefit the ...
Breaking Medicine Technology:InCrowd Helps IIeX Health 2015 Chart New Paths for Turning Physician Insights Into Innovation 2InCrowd Helps IIeX Health 2015 Chart New Paths for Turning Physician Insights Into Innovation 3Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 2Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 3Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 4Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 2Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 3
... 17, 2012 SynCardia Systems, Inc. ( www.syncardia.com ), ... Canada and CE (Europe) approved Total Artificial Heart, announced ... due in part to Certified Centers performing a record ... Artificial Heart . (Photo: http://photos.prnewswire.com/prnh/20120517/LA08709 ...
... SAN FRANCISCO, May 17, 2012  Varian Medical Systems (NYSE: ... treating early-stage inoperable lung cancer and other conditions non-invasively ... Society (ATS) later this week in San Francisco.  ... front of pulmonologists who may not be familiar with ...
Cached Medicine Technology:SynCardia Posts Record Revenue and Profit in Q1 2012 2SynCardia Posts Record Revenue and Profit in Q1 2012 3Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer 2Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer 3Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer 4
(Date:4/27/2015)... A' Design Award and Competition is pleased to ... Boombang Inc Design Team has been announced as a ... Instruments, Medical Devices and Research Equipment Design Competition ... Inc Design Team, the creative team behind the awarded ... Lumica is a two-way communication device between patients and ...
(Date:4/27/2015)... On May 15, Mount Soma Ashram students (monks) ... raise awareness of the vision of Mount Soma; the ... Ironically, when many of these people moved to the ... were leaving the social and technological world behind. Ashram ... service to a higher cause, deep introspection, and renunciation ...
(Date:4/27/2015)... April 27, 2015 The global ... a lower CAGR in developed countries; however, it ... countries such as China, India and Brazil in ... analyzers market is driven by factors such as ... laboratories, development of high-throughput hemostasis analyzers, developments in ...
(Date:4/27/2015)... 27, 2015 Healthpointe clinics throughout Southern ... nail fungi and infections. Onychomycosis, which is commonly known ... 10% of adults in the Western population. This fungal ... thickness. , Healthpointe’s Anaheim clinic is home ... dedicated to providing quality skincare products and restorative services. ...
(Date:4/27/2015)... 2015 Scooter Direct is now offering ... discounted price of only $929.00, marked down from the ... store is known for offering quality mobility solutions to ... lifts, wheel chairs, lift chairs, and their accessories at ... features of Go Go Traveller Elite, a senior store ...
Breaking Medicine News(10 mins):Health News:Boombang Inc Design Team wins Platinum in A' Medical Product Design Awards 2Health News:Mount Soma Monks Do Social Media 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 3Health News:Southern California Healthpointe Clinics Now Treating Nail Fungus 2Health News:Scooter Direct Offering Pride Go Go Traveller Elite 3-Wheel Scooter At Discounted Price 2Health News:Scooter Direct Offering Pride Go Go Traveller Elite 3-Wheel Scooter At Discounted Price 3
... Scientists seeking to harness the power of the ... hurdles: recruiting key immune cells called dendritic cells into ... found and helping them recognize tumor cells as targets ... however, have identified a sequence of molecular events that ...
... Tracey Neale, MC,s event with Rock & Roll Hall ... the nation,s biggest problem: the health of our peopleWASHINGTON, ... Inaugural Ball announced today the complete line up of ... Natural History Museum, home of the Hope Diamond. ...
... Ohio distributor recalls two King Nut brands; almost 400 in ... -- Lab tests on a tainted tub of peanut butter ... has sickened almost 400 people across the United States, Minnesota ... the Minnesota Department of Health Web site, was a follow-up ...
... The Academy of Breastfeeding Medicine feels ... be well advised to review its policy banning photographs ... that breastfeeding is an unseemly bodily function best kept ... has no place in contemporary society. It further perpetuates ...
... to consumers and purchasers , PHILADELPHIA, Jan. 12 ... awarded full accreditation in Pharmacy Benefit Management from ... that establishes quality standards for the health care ... symbol of excellence to employers, health care consumers, ...
... County Community College,District (WCCCD) has partnered with the Michigan ... oral health for foster care youth. The seminar,will be ... Student Welcome,Center on Wednesday, January 14, at 2:00 p.m. ... of the District,s Dental Program will schedule,teeth cleaning appointments ...
Cached Medicine News:Health News:Gene therapy eliminates brain tumors through selective recruitment of immune cells 2Health News:Gene therapy eliminates brain tumors through selective recruitment of immune cells 3Health News:Health for All Inaugural Ball Brings Renowned Speakers and Entertainment to Election's Key Issue 2Health News:Health for All Inaugural Ball Brings Renowned Speakers and Entertainment to Election's Key Issue 3Health News:Minn. Confirms Tainted Peanut Butter Link to Salmonella Outbreak 2Health News:Facebook Flack Regarding Breastfeeding Mothers 2Health News:FutureScripts(R) Earns URAC Pharmacy Benefit Manager Accreditation 2Health News:WCCCD Partners With Michigan Department of Human Services to Present a Dental Health Seminar to Foster Care Youth 2
... of German Craftsmanship have produced ... the world. Ocutek now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
1mm by 7mm horizontal punch. Flat serrated handle. Overall length 87mm....
... integrated neck. Piston assembly fits into ... spring to recoil back to ready ... into precision milled cavity in platform. ... - 9.0mm. Designed for the preparation ...
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
Medicine Products: